Hypertension is an increasingly common chronic condition in children and adolescents that may be managed by primary care physicians and/or subspecialists. Prescription of safe and cost-effective antihypertensive medications to children and adolescents with hypertension is essential to ensuring the best possible clinical and economic outcomes. However, there are no clear evidence-based guidelines to direct pharmacologic management of hypertension in children and adolescents. The proposed project aims to identify which physicians prescribe antihypertensive medications to children and adolescents;explore the factors that influence antihypertensive medication choice;examine the generalist-subspecialist interface in the co- management of hypertension in children and adolescents;and develop recommendations for potential co- management models for different combinations of clinicians of various medical specialties involved in the management of children and adolescents with hypertension. The project is organized into 4 phases: (1) Analysis of administrative data to provide an overview of antihypertensive medication utilization and description of physicians who prescribe antihypertensives to children and adolescents with hypertension;(2) Physician interviews to identify factors influencing physician pharmacologic management decisions and the roles and expectations of generalists and subspecialists in co-management of children with hypertension;(3) Physician surveys to further explore factors associated with physician pharmacologic management decisions and the roles and expectations of generalists and subspecialists in co-management of children with hypertension;and (4) Development of recommendations for potential models of co-management of children and adolescents with hypertension. Career development activities will include formal training in statistical analysis of clinical data, qualitative methods, survey methods, and clinical decision-making, with guidance and direction from a panel of dedicated and experienced mentors.
Because antihypertensive medications are often expensive and long-term therapies, a greater understanding of the existing organization and delivery of health care services to children and adolescents is an essential step toward prescribing safe and cost-effective antihypertensive medications to children and adolescents with hypertension.
|Yoon, Esther; McCool, Brigitte; Filipp, Stephanie et al. (2015) Pediatric Hypertension Specialists' Perspectives About Adolescent Hypertension Management: Implications for Primary Care Providers. Clin Pediatr (Phila) 54:551-6|
|Yoon, Esther Y; Cohn, Lisa; Freed, Gary et al. (2014) Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension. J Adolesc Health 55:73-8|
|Yoon, Esther Y; Weber, Julie S; McCool, Brigitte et al. (2013) Underlying Rationale and Approach to Treat Hypertension in Adolescents by Physicians of Different Specialty. Ann Pediatr Child Health 1:|
|Yoon, Esther Y; Cohn, Lisa; Rocchini, Albert et al. (2012) Clonidine utilization trends for Medicaid children. Clin Pediatr (Phila) 51:950-5|
|Yoon, Esther Y; Cohn, Lisa; Rocchini, Albert et al. (2012) Use of diagnostic tests in adolescents with essential hypertension. Arch Pediatr Adolesc Med 166:857-62|
|Yoon, Esther Y; Cohn, Lisa; Rocchini, Albert et al. (2012) Antihypertensive prescribing patterns for adolescents with primary hypertension. Pediatrics 129:e1-8|
|Lee, Joyce M; Wu, En-Ling; Tarini, Beth et al. (2011) Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents? J Pediatr 158:947-952.e1-3|